The Point of Care Technology Market is developing alongside a broader transformation in healthcare delivery toward convenient, technology-enabled diagnostics. According to WiseGuyReports, the market reached USD 35.2 billion in 2025 and is expected to grow to USD 50 billion by 2035 at a CAGR of 3.6%.

A diverse product landscape supports this expansion. Glucose monitoring devices, cardiac monitoring devices, infectious disease testing devices, breath analyzers, and urinalysis strips serve different diagnostic requirements. Glucose monitoring is particularly significant, with the segment projected to increase from USD 8 billion in 2024 to USD 12 billion by 2035.

The market is also moving beyond traditional clinical environments. Home care and ambulatory settings are becoming increasingly relevant as patients and healthcare providers seek convenient testing options. Point-of-care technologies can support decentralized care models while complementing telemedicine and remote patient monitoring services.

North America currently maintains a strong market position, while Asia Pacific offers substantial growth potential due to rising healthcare expenditure and improving medical infrastructure. Europe is also adopting new point-of-care technologies as healthcare systems focus on patient-centered services and innovation.

Looking ahead, AI-enabled diagnostics, IoT connectivity, portable instruments, and improved interoperability are likely to influence product development. The combination of rapid testing, digital connectivity, and personalized healthcare could strengthen the role of point-of-care technology across both established and emerging healthcare markets.